Portfolio company
Noara Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Novarna
This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.
Kerna
This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
Synthetic biology-powered mRNA therapeutics
The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
